Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1

Niessner, Heike; Kosnopfel, Corinna; Sinnberg, Tobias; Beck, Daniela; Krieg, Kathrin; Wanke, Ines; Lasithiotakis, Konstantinos; Bonin, Michael; Garbe, Claus; Meier, Friedegund

dc.contributor.author	Niessner, Heike
dc.contributor.author	Kosnopfel, Corinna
dc.contributor.author	Sinnberg, Tobias
dc.contributor.author	Beck, Daniela
dc.contributor.author	Krieg, Kathrin
dc.contributor.author	Wanke, Ines
dc.contributor.author	Lasithiotakis, Konstantinos
dc.contributor.author	Bonin, Michael
dc.contributor.author	Garbe, Claus
dc.contributor.author	Meier, Friedegund
dc.date.accessioned	2017-11-28T13:17:13Z
dc.date.available	2017-11-28T13:17:13Z
dc.date.issued	2017
dc.identifier.issn	1600-0625
dc.identifier.uri	http://hdl.handle.net/10900/78797
dc.language.iso	en	en
dc.publisher	Wiley	de_DE
dc.relation.uri	http://dx.doi.org/10.1111/exd.13372
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_00254
utue.publikation.seiten	598-606	de_DE
utue.personen.roh	Niessner, Heike
utue.personen.roh	Kosnopfel, Corinna
utue.personen.roh	Sinnberg, Tobias
utue.personen.roh	Beck, Daniela
utue.personen.roh	Krieg, Kathrin
utue.personen.roh	Wanke, Ines
utue.personen.roh	Lasithiotakis, Konstantinos
utue.personen.roh	Bonin, Michael
utue.personen.roh	Garbe, Claus
utue.personen.roh	Meier, Friedegund
dcterms.isPartOf.ZSTitelID	Experimental Dermatology	de_DE
dcterms.isPartOf.ZS-Issue	SI	de_DE
dcterms.isPartOf.ZS-Volume	26	de_DE
utue.fakultaet	04 Medizinische Fakultät